Article
Targeted treatment of autoimmune cytopenias in primary immunodeficiencies.
Frontiers in immunology - 1 Jan 2022
Pacillo Lucia, Giardino Giuliana, Amodio Donato, Giancotta Carmela, Rivalta Beatrice, Rotulo Gioacchino Andrea, Manno Emma Concetta, Cifaldi Cristina, Palumbo Giuseppe, Pignata Claudio, Palma Paolo, Rossi Paolo, Finocchi Andrea, Cancrini Caterina
Abstract excerpt
Primary Immunodeficiencies (PID) are a group of rare congenital disorders of the immune system. Autoimmune cytopenia (AIC) represents the most common autoimmune manifestation in PID patients. Treatment of AIC in PID patients can be really challenging, since they are often chronic, relapsing and refractory to first line therapies, thus requiring a broad variety of alternative therapeutic options. Moreover,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.